Jorge O Galante

20110022179, Jan 27, 2011

Jun 15, 2010

12/815730

Thomas P. Andriacchi - Los Altos Hills CA, US
Jorge O. Galante - Sanibel FL, US

A61F 2/38

623 2018, 623 2021

A knee replacement system, and a method for supplying and implanting a knee replacement system, for enabling natural knee movement in a leg in a patient, including: a medial femoral component having a medial femoral articulating surface with a sagittal plane profile including four medial femoral arcuate portions scaled by a first femoral scaling factor; a lateral femoral component having a lateral femoral articulating surface with a sagittal plane profile including four lateral femoral arcuate portions scaled by a second femoral scaling factor; a medial tibial component having a medial tibial articulating surface that articulates with the medial femoral articulating surface and includes a first raised medial edge that increases in width in an anterior direction; and a lateral tibial component having a lateral tibial articulating surface that articulates with the lateral femoral articulating surface and includes a second raised medial edge that increases in width in the anterior direction.

20130103159, Apr 25, 2013

Dec 17, 2012

13/716331

Jorge O. Galante - Sanibel FL, US

BIOMET MANUFACTURING CORP. - Warsaw IN

A61F 2/38

623 2028

A method of implanting a knee replacement system in a leg with a femur and a tibia of a patient can include, implanting a femoral component onto a condyle of the femur and placing a trial tibial component on a tibial plateau of the tibia. The tension of a posterior cruciate ligament can be adjusted. The tension of an anterior cruciate ligament can be adjusted. The posterior position of the trial tibial component can be adjusted. The knee condition at toe off onset can be simulated during walking.

45368945, Aug 27, 1985

Aug 4, 1983

6/520347

Jorge O. Galante - Oak Brook IL
William Rostoker - Chicago IL

A61F 104

623 22

A femoral hip prosthesis is provided with porous bony ingrowth material on each of the anterior and posterior sides. The bone ingrowth materials on each side flare or expand outwardly in the proximal direction with respect to the sides of the prosthesis, to provide a wedge shaped configuration of at least 1 millimeter increase in thickness at the upper proximal end of the porous materials from the point where the expansion begins. By impacting the prosthesis in the surgically prepared opening in the femoral canal a wedge tight fitting is achieved to assure initial stabilization of the prosthesis for a sufficiently long period of time, e. g. about six weeks or more, until bony ingrowth into the porous materials has occurred to provide long term stabilization. The distal end of the stem of the prosthesis is chamfered anteriorly and posteriorly so that the prosthesis can be used for either the right leg femur or left leg femur without impinging on the anterior bow.

20170128218, May 11, 2017

Jan 23, 2017

15/412695

- Warsaw IN, US
Jorge O. Galante - Sanibel FL, US

A61F 2/38
A61F 2/46

A knee replacement system, and a method for supplying and implanting a knee replacement system, for enabling natural knee movement in a leg in a patient, including: a medial femoral component having a medial femoral articulating surface with a sagittal plane profile including four medial femoral arcuate portions scaled by a first femoral scaling factor; a lateral femoral component having a lateral femoral articulating surface with a sagittal plane profile including four lateral femoral arcuate portions sealed by a second femoral scaling factor; a medial tibial component having a medial tibial articulating surface that articulates with the medial femoral articulating surface and includes a first raised medial edge that increases in width in an anterior direction; and a lateral tibial component having a lateral tibial articulating surface that articulates with the lateral femoral articulating surface and includes a second raised medial edge that increases in width in the anterior direction.

20160333410, Nov 17, 2016

Jan 14, 2015

15/111395

- Chicago IL, US
- Urbana IL, US
John Sandy - Chicago IL, US
Rebecca Bell - New York NY, US
Jorge Galante - Sanibel FL, US
Katie J. Trella - Chicago IL, US

RUSH UNIVERSITY MEDICAL CENTER - Chicago IL
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS - Urbana IL

C12Q 1/68
A61K 38/18
A61K 38/43
G01N 33/68

A method for monitoring a treatment of a subject having a musculoskeletal disorder is provided. The method includes measuring a first expression level of at least two biomarkers at a treatment site prior to the treatment and measuring a second expression level of the at least two biomarkers at the treatment site after the treatment begins. The method further includes comparing the first expression level of the at least two biomarkers prior to the treatment to the second expression level of the at least two biomarkers post treatment and continuing the treatment, altering the treatment or stopping the treatment based on the comparison. A method of treating a musculoskeletal disorder in a subject is also provided. The method includes removing a aggrecan-hyaluronan matrix from a treatment site in the subject.